308 related articles for article (PubMed ID: 30888527)
1. Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study.
Wei JL; Jiang YZ; Shao ZM
Int J Clin Oncol; 2019 Aug; 24(8):934-940. PubMed ID: 30888527
[TBL] [Abstract][Full Text] [Related]
2. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study.
Al-Husseini MJ; Mohamed HH; Saad AM; Gad MM; Atia M; Qaddoora U; Abushouk AI; El-Shinawi M
Curr Probl Cancer; 2019 Jun; 43(3):213-221. PubMed ID: 30195804
[TBL] [Abstract][Full Text] [Related]
3. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
[TBL] [Abstract][Full Text] [Related]
4. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors.
Calip GS; Law EH; Ko NY
Breast Cancer Res Treat; 2015 Jun; 151(3):687-96. PubMed ID: 26012645
[TBL] [Abstract][Full Text] [Related]
5. Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis.
Liu J; Jiang W; Mao K; An Y; Su F; Kim BY; Liu Q; Jacobs LK
Breast Cancer Res Treat; 2015 Apr; 150(2):439-45. PubMed ID: 25764167
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
[TBL] [Abstract][Full Text] [Related]
7. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.
Farr DE; Thomas A; Khan SA; Schroeder MC
Oncologist; 2017 Aug; 22(8):895-900. PubMed ID: 28487463
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.
Wang W
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138756
[TBL] [Abstract][Full Text] [Related]
9. Risk of Second Primary Female Genital Malignancies in Women with Breast Cancer: a SEER Analysis.
Li Z; Wu Q; Song J; Zhang Y; Zhu S; Sun S
Horm Cancer; 2018 Jun; 9(3):197-204. PubMed ID: 29556910
[TBL] [Abstract][Full Text] [Related]
10. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
12. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
13. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
[TBL] [Abstract][Full Text] [Related]
14. Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.
Khanal A; Budhathoki N; Singh VP; Shah BK
Anticancer Res; 2017 Apr; 37(4):2033-2036. PubMed ID: 28373478
[TBL] [Abstract][Full Text] [Related]
15. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
[TBL] [Abstract][Full Text] [Related]
16. The association between histological subtype of a first primary endometrial cancer and second cancer risk.
Rhoades J; Vetter MH; Fisher JL; Cohn DE; Salani R; Felix AS
Int J Gynecol Cancer; 2019 Feb; 29(2):290-298. PubMed ID: 30718311
[TBL] [Abstract][Full Text] [Related]
17. Second malignancy in young early-stage breast cancer patients with modern radiotherapy: A long-term population-based study (A STROBE-compliant study).
Xie L; Lin C; Zhang H; Bao X
Medicine (Baltimore); 2018 Apr; 97(17):e0593. PubMed ID: 29703057
[TBL] [Abstract][Full Text] [Related]
18. Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.
Dadey DYA; Medress ZA; Sharma M; Ugiliweneza B; Wang D; Rodrigues A; Parker J; Burton E; Williams B; Han SS; Boakye M; Skirboll S
J Neurooncol; 2023 Sep; 164(3):655-662. PubMed ID: 37792220
[TBL] [Abstract][Full Text] [Related]
19. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
Nelson RA; Lai LL
Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
[TBL] [Abstract][Full Text] [Related]
20. The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status.
Schonfeld SJ; Curtis RE; Anderson WF; Berrington de González A
Cancer Causes Control; 2012 Oct; 23(10):1721-8. PubMed ID: 22918549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
